JOHNNY HASSERODT: Open Payments
NPI 1164716072 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,710 in 163 payments from 17 companies in 2025. Trend: 2023 $2,627 · 2024 $2,960 · 2025 $2,710
Food & beverage: $2,710
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 35 | $731 |
| ABBVIE INC. | 38 | $338 |
| Lilly USA, LLC | 21 | $312 |
| AstraZeneca Pharmaceuticals LP | 9 | $242 |
| Bayer Healthcare Pharmaceuticals Inc. | 17 | $239 |
| Sumitomo Pharma America, Inc. | 8 | $163 |
| PFIZER INC. | 7 | $146 |
| Phathom Pharmaceuticals, Inc. | 5 | $127 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $66 |
| SHIELD THERAPEUTICS INC | 4 | $58 |
Products named: Ozempic, MOUNJARO, Kerendia, Wegovy, QULIPTA, GEMTESA, FARXIGA, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
